The Motley Fool Podcasts Industry Focus Healthcare: 3 Beaten-Up Biotechs -- Are They Buys?

Healthcare: 3 Beaten-Up Biotechs -- Are They Buys? Logo

Healthcare: 3 Beaten-Up Biotechs -- Are They Buys?

Here's why post-approval setbacks have caused Puma Biotechnology, Clovis Oncology, and Regenxbio shares to tumble, and if any of these stocks are finally worth buying. Stocks: PBYI, CLVS, RGNX

Check out more of our content here:

Listen to Healthcare: 3 Beaten-Up Biotechs -- Are They Buys?

Recent Episodes

Listen
Listen
Listen
Listen
Listen